The government of Democratic Republic of Congo has given the go-ahead for an experimental Ebola vaccine to be used in the country.


The vaccine, called rVSV-ZEBOV, does not yet have a license but in a paper published at the end of last year it was shown to be highly effective, Reuters reports.

It is not yet clear how exactly the vaccine will be used in terms of when it will be distributed and who will get it.

The country is currently battling an outbreak in the north-east which has killed four people so far.